Literature DB >> 11045681

Spinal cord glioneuronal tumor with "rosetted" neuropil islands and meningeal dissemination: a case report.

B T Harris1, D S Horoupian.   

Abstract

Distinctive glioneuronal tumors arising within the cerebrum and displaying neuropil-like islands and tumor cells immunoreactive for neuronal and glial antigens have recently been described. We report a similar tumor in the cervico-thoracic region of the spinal cord in a 44-year-old woman that recurred 1 year later with dissemination to the lumbar dura and cauda equina. The tumor was composed of "rosetted" neuropil islands displaying immunoreactivity for synaptophysin, whereas the intervening tumor cells were more fibrillar and immunoreactive for GFAP. The tumor cell nuclei immediately surrounding these neuropil islands were immunoreactive to the newly characterized neuronal marker, anti-Hu. While several cases of neurocytomas have been described in the spinal cord, to the best of our knowledge, this is the first example of a glioneuronal tumor with "rosetted" neuropil islands to be reported in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045681     DOI: 10.1007/s004010000217

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

Review 1.  Neurocytoma: a comprehensive review.

Authors:  Mehar Chand Sharma; Prabal Deb; Suash Sharma; Chitra Sarkar
Journal:  Neurosurg Rev       Date:  2006-08-29       Impact factor: 3.042

2.  Glioneuronal tumor with neuropil-like islands of the spinal cord with diffuse leptomeningeal neuraxis dissemination.

Authors:  Bree Ruppert; Cynthia T Welsh; Jessica Hannah; Pierre Giglio; Zoran Rumboldt; Ian Johnson; John Fortney; Joseph M Jenrette; Sunil Patel; Bernd W Scheithauer
Journal:  J Neurooncol       Date:  2010-12-25       Impact factor: 4.130

3.  Glioneuronal tumor with unique imaging and histologic features.

Authors:  Erica F Bisson; William W Pendlebury; Michael A Horgan
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.130

Review 4.  Low-grade gliomas and leptomeningeal dissemination: a poorly understood phenomenon.

Authors:  Giorgio Perilongo; Maria Luisa Garrè; Felice Giangaspero
Journal:  Childs Nerv Syst       Date:  2003-04-05       Impact factor: 1.475

5.  Spinal cord glioneuronal tumor with neuropil-like islands with 1p/19q deletion in an adult with low-grade cerebral oligodendroglioma.

Authors:  Tyler J Fraum; Stephanie Barak; Svetlana Pack; Russell R Lonser; Howard A Fine; Martha Quezado; Fabio M Iwamoto
Journal:  J Neurooncol       Date:  2011-11-15       Impact factor: 4.130

6.  Primary neurocytoma of the spinal cord: a case report and review of literature.

Authors:  Suash Sharma; Chitra Sarkar; Shailesh Gaikwad; Ashish Suri; Mehar C Sharma
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

Review 7.  Intraventricular glioneuronal tumor with disseminated lesions at diagnosis--a case report.

Authors:  Hirohito Yano; Noriyuki Nakayama; Yoshinobu Hirose; Naoyuki Ohe; Jun Shinoda; Shin-ichi Yoshimura; Toru Iwama
Journal:  Diagn Pathol       Date:  2011-12-06       Impact factor: 2.644

8.  Spinal cord glioneuronal tumor with rosetted neuropil-like islands in pediatric age group.

Authors:  Nil Comunoglu; Ozgur Kilickesmez; Buge Oz
Journal:  Case Rep Pathol       Date:  2014-12-10

Review 9.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

10.  An individual patient data meta-analysis on characteristics and outcome of patients with papillary glioneuronal tumor, rosette glioneuronal tumor with neuropil-like islands and rosette forming glioneuronal tumor of the fourth ventricle.

Authors:  Annika Schlamann; André O von Bueren; Christian Hagel; Isabella Zwiener; Clemens Seidel; Rolf-Dieter Kortmann; Klaus Müller
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.